Concentrix (NASDAQ:CNXC) Announces Earnings Results, Misses Expectations By $0.06 EPS

Concentrix (NASDAQ:CNXC - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $2.70 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.76 by ($0.06), RTT News reports. Concentrix had a return on equity of 16.73% and a net margin of 2.81%. During the same quarter in the prior year, the company posted $2.69 EPS. Concentrix's quarterly revenue was up 1.5% compared to the same quarter last year. Concentrix updated its FY 2025 guidance to 11.530-11.760 EPS and its Q3 2025 guidance to 2.800-2.910 EPS.

Concentrix Stock Up 1.8%

Shares of Concentrix stock traded up $0.96 on Thursday, reaching $55.13. 1,602,259 shares of the company were exchanged, compared to its average volume of 732,154. The company has a market capitalization of $3.52 billion, a price-to-earnings ratio of 13.82, a PEG ratio of 0.70 and a beta of 0.56. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 1.22. Concentrix has a one year low of $36.28 and a one year high of $77.00. The company has a 50-day moving average of $53.62 and a 200 day moving average of $49.36.

Insider Activity at Concentrix

In other Concentrix news, EVP Cormac J. Twomey sold 500 shares of the stock in a transaction on Friday, May 30th. The shares were sold at an average price of $57.06, for a total value of $28,530.00. Following the completion of the sale, the executive vice president now owns 38,130 shares in the company, valued at $2,175,697.80. This trade represents a 1.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Christopher A. Caldwell bought 1,000 shares of the company's stock in a transaction dated Monday, April 21st. The stock was purchased at an average cost of $46.00 per share, for a total transaction of $46,000.00. Following the completion of the acquisition, the chief executive officer now owns 303,362 shares in the company, valued at $13,954,652. This trade represents a 0.33% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders sold 30,944 shares of company stock valued at $1,510,158. 3.20% of the stock is owned by corporate insiders.

Institutional Trading of Concentrix

A number of hedge funds have recently made changes to their positions in the business. Geneos Wealth Management Inc. increased its holdings in shares of Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock worth $34,000 after acquiring an additional 522 shares during the last quarter. Focus Partners Wealth bought a new position in Concentrix during the first quarter worth $781,000. Royal Bank of Canada increased its holdings in shares of Concentrix by 9.5% in the first quarter. Royal Bank of Canada now owns 47,501 shares of the company's stock valued at $2,643,000 after purchasing an additional 4,133 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Concentrix by 17.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company's stock valued at $8,152,000 after purchasing an additional 21,746 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its position in shares of Concentrix by 75.1% in the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company's stock valued at $23,552,000 after purchasing an additional 181,546 shares during the period. 90.34% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on CNXC shares. Bank of America increased their price objective on Concentrix from $59.00 to $65.00 and gave the stock a "neutral" rating in a report on Monday, June 9th. Robert W. Baird raised their price target on shares of Concentrix from $62.00 to $72.00 and gave the stock an "outperform" rating in a research note on Thursday. Wall Street Zen lowered shares of Concentrix from a "buy" rating to a "hold" rating in a research report on Saturday, June 21st. Finally, Barrington Research restated an "outperform" rating and set a $54.00 target price on shares of Concentrix in a report on Tuesday. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Concentrix currently has an average rating of "Moderate Buy" and an average target price of $67.75.

Concentrix Company Profile

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.